Proportionality no basis to deny fees in $7M QRxPharma class action settlement, judge says

Class Actions 2020-09-29 3:12 pm By Miklos Bolza | Sydney

A judge has approved a $7 million settlement in a class action against the directors of pharmaceutical company QRxPharma, only a third of which will go to group members, saying proportionality was not a basis for rejecting fees that were otherwise fair and reasonable.